Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Canadian Solar Inc Reports Revenue Decline in Q4 2023 Expects Lower Revenue for Q1 2024

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
Green renewable
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Canadian Solar Inc (NASDAQ: CSIQ) experienced a 14% decrease in revenue for the fourth quarter of fiscal 2023, totaling $1.70 billion, along with an EPS loss of $(0.02). Despite this decline, the company managed to boost solar module shipments by 26% year-over-year, reaching 8.2 GW.

Total module shipments hit 8.2 GW, marking a 26% increase from the previous year but a 2% decrease sequentially. The gross profit also took a hit, dropping by 39% year-over-year to $213 million, resulting in a margin contraction to 12.5% due to lower module ASPs and an inventory write-down.

Looking towards the future, Canadian Solar is expecting lower revenue and shipments for the first quarter and fiscal 2024. The company predicts total revenue of $1.20 billion – $1.40 billion for Q1, with a gross margin of 17% – 19%. They also anticipate total module shipments recognized as revenues by CSI Solar to be between 6.1 GW – 6.4 GW for the first quarter. Additionally, as of January 31, 2024, Canadian Solar has a $2.6 billion e-STORAGE contracted backlog.

Canadian Solar Inc. (CSIQ) Faces Stock Price Drop on March 14, 2024: What Investors Need to Know

Canadian Solar Inc. (CSIQ) had a rough day on March 14, 2024, as the stock experienced a 2.17% drop in its share price. Throughout the trading day, CSIQ shares fell by $0.42, closing at $19.41.

CSIQ is currently trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating a downward trend. However, past performance is not indicative of future results, and investors should conduct their own research before making any investment decisions.

The drop in CSIQ’s share price on March 14th may have been influenced by various factors such as market conditions, industry trends, or company-specific news. It is important for investors to stay informed and be aware of potential risks.

Overall, the performance of CSIQ on March 14, 2024, reflects the volatility of the stock market. It will be interesting to see how CSIQ performs in the coming days and whether it can rebound from its recent drop in share price.

Canadian Solar Inc. (CSIQ) Stock Performance and Financial Results Analysis for March 14, 2024

On March 14, 2024, Canadian Solar Inc. (CSIQ) stock performance was closely watched by investors and analysts after the company reported its financial results for the past year and the third quarter. According to data from CNN Money, CSIQ’s total revenue for the year was $7.47 billion, showing a significant increase of 41.53% compared to the previous year. However, the total revenue for the third quarter was $1.85 billion, indicating a decrease of 21.9% compared to the previous quarter.

In terms of net income, CSIQ reported a net income of $239.97 million for the year, which marked a substantial increase of 151.94% compared to the previous year. However, the net income for the third quarter was $21.89 million, showing a significant decrease of 87.12% compared to the previous quarter.

Earnings per share (EPS) for CSIQ were reported at $3.44 for the year, reflecting a notable increase of 135.91% compared to the previous year. However, the EPS for the third quarter was $0.33, indicating a significant decrease of 87.34% compared to the previous quarter.

Overall, the financial results for Canadian Solar Inc. (CSIQ) showed a mixed performance, with strong growth in total revenue and net income for the year, but a significant decline in these metrics for the third quarter. The stock performance on March 14, 2024, was likely influenced by these results, as investors assessed the company’s financial health and future prospects. Analysts may have closely monitored CSIQ’s performance to determine whether the company’s growth trajectory is sustainable and to make informed investment decisions.

Tags: CSIQ
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Exchange

Immuneering Shares Plunge as Trading Halted

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Goldman Sachs Upgrades WilliamsSonoma Rating and Price Target

Finances

Short Interest in Prospect Capital NYSEPSEC on the Rise

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com